Burges Salmon advises Edinburgh-based biotech on investment
Burges Salmon has advised Calcivis, a Scottish biotech that aims to revolutionise early-intervention diagnostics in dentistry, on its £5 million investment. The funding was provided by the Scottish National Investment Bank and IFS Maven Equity Finance, which is managed by Maven Capital Partner